MedPath

A comparative evaluation of unani formulation with rosuvastatin in the management of dyslipidaemia

Not Applicable
Conditions
Health Condition 1: E669- Obesity, unspecified
Registration Number
CTRI/2024/04/065396
Lead Sponsor
Department of Moalejat Faculty of unani medicine Ajmal khan tibbya college
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients in age group of 30-60 years

Patients of either gender

Patient willing to sign the written informed consent

Clinically stable patients of dyslipidemia with following subjective and

objective parameters

Subjective parameters:

Patient showing any one of the following symptoms will be asked to go for required

investigations & will be included in the study accordingly.

Increasing body weight

Dyspnoea on exertion

Fatigue

Xanthelasma

Corneal arcus

Joint pain

Patients having any two of the following will be included in the study:

Total Serum cholesterol ( 200-300 mg/dl)

Serum triglyceride (160-300 mg/dl)

LDL (130-190 mg/dl)

HDL (30-60 mg/dl)

LDL (30-50 mg/dl)

Exclusion Criteria

Patient below 30 years and above 60 years

Any uncontrolled systemic illness

Any type of liver disease

Patient of CAD

Uncontrolled type 2 Diabetes Mellitus

Hyperthyroidism and Hypothyroidism

Pregnant and lactating women

Alcoholic

Patient who fails to give consent

In case of worsening of symptoms patient may be withdrawn from trial and

be shifted to standard treatment.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath